//
Also known as: C/O SOLOMON BLUM HEYMANN
Emerald Foundation Inc. is a private corporation based in NEW YORK, NY. The foundation received its IRS ruling in 1998. The principal officer is % Solomon Blum Heymann & Stich. It holds total assets of $25.3M. Annual income is reported at $11.3M. The foundation operates in the area of philanthropy & grantmaking. According to available records, Emerald Foundation Inc. has made 68 grants totaling $5.2M, with a median grant of $75K. Annual giving has grown from $1.1M in 2020 to $1.4M in 2023. Grantmaking activity was highest in 2021 with $1.4M distributed across 14 grants. Individual grants have ranged from $5K to $150K, with an average award of $77K. The foundation has supported 32 unique organizations. The foundation primarily supports organizations in Massachusetts, New York, California, which account for 66% of all grants. Grantmaking reaches organizations across 8 states. Contributions to this foundation are tax-deductible.
Emerald Foundation Inc. primarily funds organizations in the area of philanthropy & grantmaking. Based on available records, the foundation has funded 68 grants. Its grantmaking reaches organizations primarily in MA, NY, CA.
Emerald Foundation Inc. has distributed a total of $5.2M across 68 grants. The median grant size is $75K, with an average of $77K. Individual grants have ranged from $5K to $150K.
Emerald Foundation Inc. typically selects its grantees rather than accepting unsolicited proposals.
Emerald Foundation Inc. is headquartered in NEW YORK, NY. While based in NY, the foundation distributes grants to organizations across 8 states.
| Name | Title | Compensation | Benefits | Total |
|---|---|---|---|---|
| James P Mahaffey | Vice President | $119K | $0 | $119K |
| Erika Kellerhals | Director | $0 | $0 | $0 |
| William Blum | Treasurer | $0 | $0 | $0 |
| Luca Cantelli | Director | $0 | $0 | $0 |
| Andrew W Heymann | Pres/director | $0 | $0 | $0 |
Total Giving
$2.2M
Total Assets
$26.4M
Fair Market Value
$28.2M
Net Worth
$26.4M
Grants Paid
$1.4M
Contributions
$0
Net Investment Income
$620K
Distribution Amount
$1.4M
Total: $25.8M
Total Grants
68
Total Giving
$5.2M
Average Grant
$77K
Median Grant
$75K
Unique Recipients
32
Most Common Grant
$38K
of 2023 grantees were first-time recipients
| Recipient | Location | Amount | Year |
|---|---|---|---|
| University Of Md Baltimore FoundatiTO INVESTIGATE THE REGULATION OF TREG LYMPHATIC TUMOR MIGRATION AND THE INTERACTION AMONG TREGS, LYMPHATIC ENDOTHELIAL CELLS, AND TUMORS TO DEVELOP STRATEGIES OF DELIVERING TARGETED THERAPIES LOCALLY INSTEAD OF SYSTEMICALLY. | Baltimore, MD | $150K | 2023 |
| Inserm Dr Grand OuestTO DETERMINE THE MECHANISM THROUGH WHICH BREAST CANCER CELL CLUSTERS DISSOCIATE INTO SINGLE CELLS AND PROLIFERATE AT DISTANT SITES AND TO DETERMINE THE IMPACT OF THE NEW ENVIRONMENT ON METASTASIS FORMATION. | Nantes | $100K | 2023 |
| University Of KyTO UNDERSTAND HOW MALADAPTIVE CHANGES TO THE INTEGRATED STRESS RESPONSE PATHWAY ALTER THE FORCE GENERATING ABILITY OF HUMAN HEART CELLS AND DETERMINE IF PHARMACOLOGICAL MANIPULATION CAN RESCUE CARDIOMYOCYTE FUNCTION. | Lexington, KY | $100K | 2023 |
| John Hopkins UniversityTO INVESTIGATE HOW THE COLON MICROBIOTA AND HOST GENETICS INTERSECT TO ALTER RESPONSIVENESS TO IMMUNOTHERAPY IN COLORECTAL CANCER. |
| 2018 | 990PF | View |
| 2017 | 990PF | View |
| 2016 | 990PF | View |
| Baltimore, MD |
| $100K |
| 2023 |
| Dana-Farber Cancer InstituteTO MAP THE TRANSCRIPTIONAL AND PROTEIN CHANGES INDUCED BY LACTATE AND IDENTIFY THE MECHANISMS THAT CAUSE NK SUPPRESSION, ON BOTH NK AND TUMOR CELLS, USING HIGH-THROUGHPUT AND UNBIASED APPROACHES. | Boston, MA | $100K | 2023 |
| Ma Institute Of TechnologyTO ENHANCE NANOPARTICLE ACCUMULATION IN DESIRED CELL TYPES TO DEVELOP MORE EFFECTIVE AND SAFER TARGETED NANOTHERAPIES. | Cambridge, MA | $75K | 2023 |
| Joan Sanford I Weill MedicalTO IDENTIFY REGULATORS OF LINEAGE REVERSION THAT IMPACT RESISTANCE TO WNT-TARGETED THERAPIES IN COLORECTAL CANCER. | New York, NY | $75K | 2023 |
| Salk Institute For Bio StudiesTO USE INNOVATIVE CELL BIOLOGY TECHNIQUES COUPLED WITH GENOMICS TO INVESTIGATE THE ROLE OF MITOCHONDRIAL-DERIVED VESICLES IN CANCER CELL METABOLISM. | La Jolla, CA | $50K | 2023 |
| Whitehead Institute For BiomedTO UNCOVER THE SET OF CELL-SURFACE PROTEINS THAT MEDIATE ESSENTIAL INTERACTIONS BETWEEN PDAC CELLS AND THEIR MICROENVIRONMENT. | Cambridge, MA | $50K | 2023 |
| Who We Play For IncTO SCREEN YOUNG STUDENTS FOR PREVIOUSLY UNDIAGNOSED HEART AILMENTS AND GENERATE DATA THAT CAN BE USED TO TRAIN AI PROGRAMS TO BETTER EVALUATE ELECTROCARDIOGRAMS. | Cocoa Beach, FL | $38K | 2023 |
| Institute For Cancer ResearchTO INVESTIGATE THE ROLE OF BRG1-DEPENDENT EPIGENETIC REGULATION ON PDAC FIBROBLAST PRO-TUMORIGENIC FUNCTIONS. | Philadelphia, PA | $38K | 2023 |
| Ca Insitute Of TechnologyTO DEVELOP INTERPRETABLE MACHINE LEARNING METHODS THAT LINK SPATIAL PHENOTYPES IN IMAGING DATA OF SOLID TUMORS WITH PATIENT OUTCOMES. | Pasadena, CA | $38K | 2023 |
| President Fellows Of HarvardTO STUDY HOW SLC7A5 REGULATES METABOLIC REPROGRAMMING AND SIGNALING PATHWAYS THAT ENABLE CANCER CELLS TO SURVIVE CDK4/6I TREATMENT. | Boston, MA | $38K | 2023 |
| Ca Institute Of TechnologyTO DEVELOP INTERPRETABLE MACHINE LEARNING METHODS THAT LINK SPATIAL PHENOTYPES IN IMAGING DATA OF SOLID TUMORS WITH PATIENT OUTCOMES. | Pasadena, CA | $38K | 2023 |
| Weill Med College Of Cornell UTO IDENTIFY REGULATORS OF LINEAGE REVERSION THAT IMPACT RESISTANCE TO WNT-TARGETED THERAPIES IN COLORECTAL CANCER. | New York, NY | $150K | 2022 |
| University Of GuelphTO IDENTIFY COMBINATIONS OF COMMERCIAL BACTERIAL ISOLATES THAT SUPPRESS KLEBSIELLA PNEUMONIAE IN THE COLON AND THE UNDERLYING COOPERATIVE MECHANISMS OF THIS ACTIVITY. | East Guelph | $100K | 2022 |
| Rockefeller UniversityTO INVESTIGATE THE ROLE OF TRNA-DERIVED FRAGMENTS AND THE GENES THEY REGULATE IN BREAST CANCER PROGRESSION AND METASTASIS. | New York, NY | $75K | 2022 |
| Univeristy Of Ca San FranciscoTO DEVELOP A SMALL MOLECULE THAT STABILIZES MUTANT P53 IN CANCER AND FURTHER ELABORATE THIS COMPOUND WITH THE ABILITY TO INCREASE DNA BINDING OF BOUND P53. | San Francisco, CA | $75K | 2022 |
| University Of Ca Santa BarbaraTO UNDERSTAND HOW MALADAPTIVE CHANGES TO THE INTEGRATED STRESS RESPONSE PATHWAY ALTER THE FORCE GENERATING ABILITY OF HUMAN HEART CELLS AND DETERMINE IF PHARMACOLOGICAL MANIPULATION CAN RESCUE CARDIOMYOCYTE FUNCTION. | Santa Barbara, CA | $38K | 2022 |
| Massachusetts Institute Of TechnologyTo investigate the role of diet and nutrient availability in tumor growth, progression, and response to treatment. | Cambridge, MA | $150K | 2021 |
| Brigham And Women'S Hospital IncTo uncover and validate druggable targets that can be combined with MEK/ERK inhibitors to treat RAS pathway-driven malignancies, especially melanoma. | Boston, MA | $150K | 2021 |
| Weill Cornell MedicineTo identify regulators of lineage reversion that impact resistance to WNT-targeted therapies in colorectal cancer. | New York, NY | $150K | 2021 |
| Salk Institute For Biological StudiesTo investigate the potential of CA19-9 as a therapeutic target for pancreatic cancer treatment and to discover pharmacological approaches to blocking CA19-9 production in malignant cells. | La Jolla, CA | $100K | 2021 |
| Whitehead Institute For Biomedical ResearchTo investigate the role of tRNA-derived fragments and the genes they regulate in breast cancer progression and metastasis. | Cambridge, MA | $100K | 2021 |
| Johns Hopkins UniversityTo investigate how the colon microbiota and host genetics intersect to alter responsiveness to immunotherapy in colorectal cancer. | Baltimore, MD | $75K | 2021 |
| Memorial Sloan-Kettering Cancer CenterTo investigate the molecular mechanisms underlying how endgogenous DNA-modifying enzymes lead to cancer genome evolution. | New York, NY | $75K | 2021 |
| Fox Chase Cancer CenterTo investigate the role of Brg1-depedent epigenetic regulation on PDAC fibroblast pro-tumorigenic functions. | Philadelphia, PA | $75K | 2021 |
| Rockefeller UniverstityTo investigate the role of tRNA-derived fragments and the genes they regulate in breast cancer progression and metastasis. | New York, NY | $75K | 2021 |
| Nyu School Of MedicineTo investigate how metabolic rewiring in distinct genetic subtypes of lung cancer impacts immune cell infiltration and leads to immune evasion. | New York, NY | $75K | 2021 |
| University Of California San FranciscoTo develop a small molecule that stabilizes mutant P53 in cancer and further elaborate this compound with the ability to increase DNA binding of bound P53. | San Francisco, CA | $75K | 2021 |
| Regents Of The University Of CaliforniaTo (1) define a microbiome growth curce in healthy children, (2) determine when and why deviation from this curve occurs, and (3) investigate known, as well as discover new, microbiome-linked disorders and relationships among them, and analyze microbiome associations with clinical presentations of COVID-19. | La Jolla, CA | $150K | 2020 |
| University Of ChicagoTo identify combinations of commensal bacterial isolates that suppress Klebsiella pneumoniae in the colon and the underlying cooperative mechanisms of this activity. | Chicago, IL | $75K | 2020 |
© 2026 Granted AI